【结 构 式】 |
【分子编号】48201 【品名】(1S,5S,6R,10R,12S,13S,15R,18S)-15-(acetoxy)-18-[((2R,3S)-3-(benzoylamino)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-phenylpropanoyl)oxy]-13,17,20,20-tetramethyl-3,14-dioxo-12-[(triethylsilyl)oxy]-2,4,9-trioxapentacyclo[14.3.1.0(1,5).0(6,13).0(7,10)]icos-16-en-7-yl cyclopropanecarboxylate 【CA登记号】 |
【 分 子 式 】C55H75NO14Si2 【 分 子 量 】1030.36984 【元素组成】C 64.11% H 7.34% N 1.36% O 21.74% Si 5.45% |
合成路线1
该中间体在本合成路线中的序号:(VI)Paclitaxel (I) was sequentially protected at the 2'-O with tert-butyldimethylsilyl chloride and imidazole and then at the 7-O with triethylsilyl chloride to afford the bis-silyl derivative (II). Selective hydrolysis of the benzoate ester group of (II) using Triton B provided (III). The vicinal 1,2-diol group of (III) was protected as the cyclic carbonate (IV) by treatment with either triphosgene or carbonyldiimidazole. The remaining free hydroxyl group of (IV) at position 4 was then acylated with cyclopropanecarbonyl chloride (V) in the presence of lithium hexamethyldisilazide to furnish the corresponding ester (VI). Subsequent deprotection of the cyclic carbonate ester of (VI) was achieved by selective hydrolysis with LiOH to afford diol (VII). Regioselective acylation of (VII) on the 2-hydroxyl with 2,4-difluorobenzoic acid (VIII) and DCC produced ester (IX). The final desilylation step was performed by treatment with HF-pyridine.
【1】 Johnston, K.A.; Kingston, D.G.I.; Chordia, M.D.; Fairchild, C.R.; Kadow, J.F.; Long, B.H.; Yuan, H.; Jagtap, P.G.; Synthesis and bioactivity of 2,4-diacyl analogues of paclitaxel. Bioorg Med Chem 2001, 9, 1, 171. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 48197 | (1S,2S,3R,4S,7R,9S,10S,12R,15S)-12-(acetoxy)-15-[[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy]-1,4,9-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate | C45H49NO13 | 详情 | 详情 | |
(II) | 48198 | (1S,2S,3R,4S,7R,9S,10S,12R,15S)-12-(acetoxy)-15-[((2R,3S)-3-(benzoylamino)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-phenylpropanoyl)oxy]-1,4-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate | C57H77NO13Si2 | 详情 | 详情 | |
(III) | 48199 | (1S,2S,3R,4S,7R,9S,10S,12R,15S)-12-(acetoxy)-1,2,4-trihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-15-yl (2R,3S)-3-(benzoylamino)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-phenylpropanoate | C50H73NO12Si2 | 详情 | 详情 | |
(IV) | 48200 | (1S,5S,6R,7S,10R,12S,13S,15R,18S)-15-(acetoxy)-7-hydroxy-13,17,20,20-tetramethyl-3,14-dioxo-12-[(triethylsilyl)oxy]-2,4,9-trioxapentacyclo[14.3.1.0(1,5).0(6,13).0(7,10)]icos-16-en-18-yl (2R,3S)-3-(benzoylamino)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-phenylpropanoate | C51H71NO13Si2 | 详情 | 详情 | |
(V) | 14061 | Cyclopropanecarbonyl chloride; Cyclopropanecarboxylic acid chloride | 4023-34-1 | C4H5ClO | 详情 | 详情 |
(VI) | 48201 | (1S,5S,6R,10R,12S,13S,15R,18S)-15-(acetoxy)-18-[((2R,3S)-3-(benzoylamino)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-phenylpropanoyl)oxy]-13,17,20,20-tetramethyl-3,14-dioxo-12-[(triethylsilyl)oxy]-2,4,9-trioxapentacyclo[14.3.1.0(1,5).0(6,13).0(7,10)]icos-16-en-7-yl cyclopropanecarboxylate | C55H75NO14Si2 | 详情 | 详情 | |
(VII) | 48202 | (1S,2S,3R,7R,9S,10S,12R,15S)-12-(acetoxy)-15-[((2R,3S)-3-(benzoylamino)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-phenylpropanoyl)oxy]-1,2-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-4-yl cyclopropanecarboxylate | C54H77NO13Si2 | 详情 | 详情 | |
(VIII) | 35123 | 2,4-difluorobenzoic acid | 1583-58-0 | C7H4F2O2 | 详情 | 详情 |
(IX) | 48203 | (1S,2S,3R,4S,7R,9S,10S,12R,15S)-12-(acetoxy)-15-[((2R,3S)-3-(benzoylamino)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-phenylpropanoyl)oxy]-4-[(cyclopropylcarbonyl)oxy]-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl 2,4-difluorobenzoate | C61H79F2NO14Si2 | 详情 | 详情 |